Vollständiger Abstract
Worum geht es in dieser Arbeit?
Background . The available literature contains relatively few studies investigating the role of anti-human leukocyte antigen (anti-HLA) antibodies – including pre-existing antibodies, de novo synthesized antibodies, and donor-specific antibodies (DSAs) – in the prevention, diagnosis, and treatment of acute kidney transplant (KT) rejection. Materials and methods . We evaluated the prevalence and specificity of pre-existing anti-HLA antibodies, the incidence and specificity of de novo anti-HLA antibody synthesis (including DSAs), and their impact on treatment outcomes at a major national transplant center. A total of 1,663 KTs performed over an 8-year period (2016–2024) were analyzed. The study cohort comprised 962 men (57.8%) and 701 women (42.2%), with a median age of 46 years (interquartile range: 37–55 years). Prior to transplantation, 90.3% of recipients received dialysis-based renal replacement therapy, while 161 patients underwent pre-emptive KT. Results . The presence of pre-existing anti-HLA antibodies was significantly associated with a higher incidence of acute rejection episodes (p < 0.001), increased need for treatment with polyclonal antibodies (p < 0.001), a greater frequency of nonfunctioning kidney grafts (p < 0.001), and higher in-hospital mortality rates (p < 0.001). Similarly, the de novo synthesis of anti-HLA antibodies was significantly associated with an increased incidence of acute rejection (p = 0.004), a greater need for plasmapheresis as part of rejection management (p < 0.001), and a lower likelihood of a functioning kidney graft at the time of hospital discharge (p = 0.037). Conclusion. Despite the high efficacy of modern immunosuppressive regimens, acute rejection remains a major factor compromising kidney graft survival. Assessing the impact of anti-HLA antibodies on KT outcomes therefore remains a pressing issue in modern KT.
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- A. G. Balkarov, N. V. Borovkova, Yu. A. Anisimov, N. A. Mushta, N. V. Shmarina, N. V. Doronina, V. V. Smirnova, I. V. Dmitriev
- Quelle
- Russian Journal of Transplantology and Artificial Organs
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- 1995-1191
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
A. G. Balkarov, N. V. Borovkova, Yu. A. Anisimov, N. A. Mushta, N. V. Shmarina, N. V. Doronina, V. V. Smirnova, I. V. Dmitriev (2026). The role of anti-HLA antibodies in the prevention, diagnosis, and management of antibody-mediated rejection after kidney transplant. Russian Journal of Transplantology and Artificial Organs. https://doi.org/10.15825/1995-1191-2026-3-107-114
Kontext
Themen, Förderung und Nutzung
Lizenzhinweise: Lizenz 1